Discovery of a novel genomic alteration that renders leukemic cells resistant to CD19-targeted immunotherapies.

ABSTRACT:

SUBMITTER: Ghobadi A 

PROVIDER: S-EPMC9582720 | biostudies-literature | 2022 Oct

REPOSITORIES: biostudies-literature